Yi Kang
Impact in
- Cancer Research top 10%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Hepatology top 10%
- Liver physiology and pathology
Papers in
-
- RNA modifications and cancer 9
- Epidemiology 23
- Congenital Heart Disease Studies 8
- Infective Endocarditis Diagnosis and Management 5
- Co-authors
- Jia Shang (17 shared papers)Yanli Zeng (9 shared papers)Xiaoju Zhang (6 shared papers)Guangzhi Liu (1 shared paper)Zhaogang Dong (1 shared paper)Li Ma (3 shared papers)Kehu Yang (5 shared papers)Tao You (20 shared papers)
- Journals
- PLoS ONE (4 papers)Medicine (3 papers)Biomedicine & Pharmacotherapy (2 papers)Environmental Science and Pollution Research (2 papers)European Journal of Nuclear Medicine and Molecular Imaging (2 papers)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Yi Kang
77 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 115
- Cancer Research 280
- Hepatology 84
- Molecular Biology 510
- Immunology 154
- Oncology 167
Countries citing papers authored by Yi Kang
This map shows the geographic impact of Yi Kang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yi Kang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yi Kang more than expected).
Fields of papers citing papers by Yi Kang
This network shows the impact of papers produced by Yi Kang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yi Kang. The network helps show where Yi Kang may publish in the future.
Co-authors
The 25 scholars most cited alongside Yi Kang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 83 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 110 | |
| 2 | 2022 | 81 | |
| 3 | 2012 | 75 | |
| 4 | 2012 | 52 | |
| 5 | 2017 | 51 | |
| 6 | 2018 | 40 | |
| 7 | 2012 | 40 | |
| 8 | 2014 | 37 | |
| 9 | 2013 | 33 | |
| 10 | 2017 | 33 | |
| 11 | 2013 | 32 | |
| 12 | 2014 | 30 | |
| 13 | 2012 | 30 | |
| 14 | 2021 | 27 | |
| 15 | 2020 | 27 | |
| 16 | 2015 | 26 | |
| 17 | 2010 | 26 | |
| 18 | 2012 | 21 | |
| 19 | 2019 | 21 | |
| 20 | 2021 | 19 |
About Yi Kang
Yi Kang is a scholar working on Molecular Biology, Epidemiology, Surgery, Cardiology and Cardiovascular Medicine and Immunology, having authored 83 papers that have together received 1.1k indexed citations. Recurring topics across this work include RNA modifications and cancer (9 papers), Congenital Heart Disease Studies (8 papers), Cancer-related molecular mechanisms research (8 papers), MicroRNA in disease regulation (7 papers), COVID-19 Clinical Research Studies (6 papers), Cardiac Valve Diseases and Treatments (6 papers), Cardiac Structural Anomalies and Repair (5 papers) and Infective Endocarditis Diagnosis and Management (5 papers). The work is most often cited by research in Cancer Research (280 citations), Hepatology (84 citations), Molecular Biology (510 citations), Immunology (154 citations) and Oncology (167 citations). Yi Kang has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Jia Shang, Yanli Zeng, Xiaoju Zhang, Guangzhi Liu, Zhaogang Dong, Li Ma, Kehu Yang, Tao You, Zheng Wang and Wei Li. Their work appears in journals such as PLoS ONE, Medicine, Biomedicine & Pharmacotherapy, Environmental Science and Pollution Research and European Journal of Nuclear Medicine and Molecular Imaging.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.